UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 30, 2004
Commission File No. 0-11178
-------
UTAH MEDICAL PRODUCTS, INC.
---------------------------
(Exact name of Registrant as specified in its charter)
UTAH 87-0342734
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
7043 South 300 West
Midvale, Utah 84047
-------------------
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
--------------
--------------------------------------------------------------------------------
ITEM 3.03 - MATERIAL MODIFICATION OF RIGHTS OF SECURITY HOLDERS
--------------------------------------------------------------------------------
On September 30, 2004, a Rights Agreement between Utah Medical Products, Inc.
(UTMD) and Registrar and Transfer Company, UTMD's transfer agent, was signed.
The Agreement, dated July 30, 2004, becomes effective on October 28, 2004, the
day UTMD's existing rights agreement expires. The new Rights Agreement is
substantively similar to the expiring agreement. A copy of the Rights Agreement
is attached hereto as Exhibit 99.1
--------------------------------------------------------------------------------
SIGNATURES
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
---------------------------
REGISTRANT
Date: 9/30/04 By: /s/ Kevin L. Cornwell
------------------- ---------------------
Kevin L. Cornwell
CEO